Delivery Order SPE2DB22D1041-SPE2DB24FUBP2

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $2,237.58, is for the delivery of 4564759800 - IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication. The order has a completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,225.05 firm fixed-price contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty medication. The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,221.57 Delivery Order contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a pharmaceutical product. The contract does not have a set-aside designation and has an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication, at a ceiling value of $1,180.88. The contract has a firm fixed price pricing type and a period of performance ending on May 22, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This award is a delivery order under contract SPE2DX15D6044, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,476.05 firm-fixed-price order is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication. The order has an ultimate completion date of August 13, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,120.82 and is for the delivery of IMITREX 4 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication. The contract is a firm fixed-price, delivery order type with a period of performance through February 4, 2025. This contract award is not associated with a set-aside program....
This is a Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 mL Injection Pens. The contract has a ceiling value of $3,681.36 and a completion date of May 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of a specific pharmaceutical product, IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, with a ceiling value of $1,093.19. The contract is a Firm Fixed Price, Delivery Order type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML. The $1,180.88 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) on April 19, 2024, with a completion date of April 22, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of the pharmaceutical product Imitrex 6 mg/0.5 ml pen injector, with a ceiling value of $1,510.23 and a performance period through May 8, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUBP2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The order is for IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, with a ceiling value of $6,166.58 and a period of performance through May 21, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This delivery order is not associated with a set-aside program.

Generated 8/25/24, 12:41 AM